Kyle Richard G insider trades
Kyle Richard G has filed 93 Form 4s with the SEC that we hold, for Timken Co (TKR) (Director), Sonoco Products Co (SON) (Director) and Sotera Health Co (SHC) (Director). Across all of them we count 0 purchases worth $0 and 43 sales worth $63.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 8 sales ($14.9M). The largest single trade was a sale of 37,181 shares of Timken Co worth $4.4M, dated 2026-05-08. The first filing on our record is dated 2021-07-06 and the latest 2026-10-05.
Timken Co (TKR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-08-10 | S, sale reported on Form 4 | 7,478 | $503.7K | 2022-08-12 | SEC |
| 2022-10-31 | S, sale reported on Form 4 | 7,402 | $520.0K | 2022-11-02 | SEC |
| 2022-10-31 | S, sale reported on Form 4 | 8,471 | $595.7K | 2022-11-02 | SEC |
| 2022-11-14 | S, sale reported on Form 4 | 16,676 | $1.2M | 2022-11-15 | SEC |
| 2022-11-22 | S, sale reported on Form 4 | 16,650 | $1.2M | 2022-11-23 | SEC |
| 2023-02-13 | S, sale reported on Form 4 | 15,973 | $1.4M | 2023-02-14 | SEC |
| 2023-02-13 | S, sale reported on Form 4 | 7,105 | $606.4K | 2023-02-14 | SEC |
| 2023-02-14 | S, sale reported on Form 4 | 23,850 | $2.0M | 2023-02-16 | SEC |
| 2023-02-21 | S, sale reported on Form 4 | 23,859 | $2.0M | 2023-02-23 | SEC |
| 2023-02-27 | S, sale reported on Form 4 | 24,841 | $2.1M | 2023-02-28 | SEC |
| 2023-05-10 | S, sale reported on Form 4 | 24,851 | $1.8M | 2023-05-11 | SEC |
| 2023-05-16 | S, sale reported on Form 4 | 23,232 | $1.7M | 2023-05-17 | SEC |
| 2023-05-23 | S, sale reported on Form 4 | 7,392 | $554.8K | 2023-05-25 | SEC |
| 2023-05-23 | S, sale reported on Form 4 | 17,040 | $1.3M | 2023-05-25 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 29,843 | $2.4M | 2023-08-08 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 2,090 | $168.6K | 2023-08-08 | SEC |
| 2023-08-14 | S, sale reported on Form 4 | 32,379 | $2.5M | 2023-08-15 | SEC |
| 2023-08-16 | S, sale reported on Form 4 | 11,000 | $849.3K | 2023-08-18 | SEC |
| 2023-08-16 | S, sale reported on Form 4 | 13,000 | $994.8K | 2023-08-18 | SEC |
| 2023-08-23 | S, sale reported on Form 4 | 20,000 | $1.5M | 2023-08-25 | SEC |
| 2024-05-02 | S, sale reported on Form 4 | 20,000 | $1.8M | 2024-05-06 | SEC |
| 2024-05-03 | S, sale reported on Form 4 | 20,000 | $1.8M | 2024-05-06 | SEC |
| 2024-05-03 | S, sale reported on Form 4 | 10,000 | $902.1K | 2024-05-06 | SEC |
| 2024-05-14 | S, sale reported on Form 4 | 15,000 | $1.4M | 2024-05-15 | SEC |
| 2024-05-14 | S, sale reported on Form 4 | 15,000 | $1.4M | 2024-05-15 | SEC |
| 2024-08-05 | S, sale reported on Form 4 | 30,000 | $2.4M | 2024-08-06 | SEC |
| 2024-08-08 | S, sale reported on Form 4 | 30,000 | $2.4M | 2024-08-12 | SEC |
| 2024-08-15 | S, sale reported on Form 4 | 20,000 | $1.7M | 2024-08-19 | SEC |
| 2024-11-08 | S, sale reported on Form 4 | 26,700 | $2.0M | 2024-11-12 | SEC |
| 2024-11-08 | S, sale reported on Form 4 | 3,300 | $254.4K | 2024-11-12 | SEC |
| 2024-11-12 | S, sale reported on Form 4 | 32,764 | $2.5M | 2024-11-14 | SEC |
| 2025-02-18 | S, sale reported on Form 4 | 17,001 | $1.4M | 2025-02-20 | SEC |
| 2025-02-19 | S, sale reported on Form 4 | 10,000 | $827.5K | 2025-02-20 | SEC |
| 2025-02-21 | S, sale reported on Form 4 | 10,380 | $863.1K | 2025-02-24 | SEC |
| 2025-02-25 | S, sale reported on Form 4 | 15,000 | $1.2M | 2025-02-26 | SEC |
| 2025-11-25 | S, sale reported on Form 4 | 15,837 | $1.3M | 2025-11-26 | SEC |
| 2026-02-06 | S, sale reported on Form 4 | 30,206 | $3.2M | 2026-02-10 | SEC |
| 2026-02-19 | S, sale reported on Form 4 | 10,000 | $1.1M | 2026-02-23 | SEC |
| 2026-02-20 | S, sale reported on Form 4 | 14,372 | $1.6M | 2026-02-24 | SEC |
| 2026-02-20 | S, sale reported on Form 4 | 5,264 | $565.1K | 2026-02-24 | SEC |
| 2026-05-08 | S, sale reported on Form 4 | 37,181 | $4.4M | 2026-05-12 | SEC |
| 2026-05-27 | S, sale reported on Form 4 | 8,448 | $1.1M | 2026-05-29 | SEC |
| 2026-08-10 | S, sale reported on Form 4 | 13,637 | $1.7M | 2026-08-11 | SEC |
Sonoco Products Co (SON)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Sotera Health Co (SHC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1507947) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
